Patient-controlled analgesic infusion devices allow patients to self-administer narcotic analgesics within the limits prescribed by the physician. PCA therapy is typically used for postoperative, obstetric, terminally ill, and trauma patients. PCA pumps deliver solutions intravenously, subcutaneously, or epidurally and allow patient activation by means of a pendant button on a cord connected to the pump or a button directly on the pump.

The global Patient-controlled Analgesic Infusion Pumps market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Patient-controlled Analgesic Infusion Pumps volume and value at global level, regional level and company level. From a global perspective, this report represents overall Patient-controlled Analgesic Infusion Pumps market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Patient-controlled Analgesic Infusion Pumps in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Patient-controlled Analgesic Infusion Pumps manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
CME Medical
BD
Medtronic
Baxter
B. Braun
Mindray Medical
Micrel Medical Devices
Insulet Corporation

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Syringe-Type
Cassette-Based Fluid Delivery Type

Segment by Application
Hospitals
Clinics
Others